Invasive Breast Cancer Stage III
Showing 9976 - 10000 of >10,000
Cicatrix, Breast Reconstruction Trial in Stanford (Neodyne Device)
Recruiting
- Cicatrix
- Breast Reconstruction
- Neodyne Device
-
Stanford, CaliforniaStanford University Medical Center
Oct 31, 2022
Advanced BRAFV600 Wild-type Melanoma Trial in Worldwide (Cobimetinib, Atezolizumab, Pembrolizumab)
Terminated
- Advanced BRAFV600 Wild-type Melanoma
- Cobimetinib
- +2 more
-
Tucson, Arizona
- +120 more
Aug 24, 2022
The ICE WATCHMAN Trial
Enrolling by invitation
- Left Atrial Appendage Closure With WATCHMAN Device Utilizing an Intra-procedural ICE Probe
- WATCHMAN device implant procedure utilizing ICE probe
-
Santa Monica, California
- +1 more
Nov 3, 2022
Intrahepatic Cholangiocarcinoma Trial in Germany (Durvalumab, Tremelimumab)
Recruiting
- Intrahepatic Cholangiocarcinoma
-
Dresden, Germany
- +7 more
Apr 13, 2022
Complications in Older Gynecologic Cancer Undergoing Surgery
Completed
- Endometrial Serous Adenocarcinoma
- +9 more
- Comprehensive Geriatric Assessment
- Questionnaire Administration
-
Birmingham, Alabama
- +392 more
Nov 23, 2021
Covid-19 Vaccine Trial (PIKA COVID-19 vaccine)
Not yet recruiting
- Covid-19 Vaccine
- PIKA COVID-19 vaccine
- (no location specified)
Jul 17, 2022
End Stage Liver Disease Trial in Boston (LYG-LIV0001)
Enrolling by invitation
- End Stage Liver Disease
- LYG-LIV0001
-
Boston, Massachusetts
- +1 more
Jan 30, 2023
CZ Using the Detection of HPV DNA and CINtec Plus
Completed
- Algorithm for Cervix Carcinoma Screening
- HPV DNA test with selective HPV 16/18 genotyping (cobas® 4800 HPV Test, Roche)
- +2 more
-
Praha, Czech Republic, CzechiaAeskulab Patologie, ks
Oct 11, 2022
Breast Cancer Trial in New York (Arm 1 Daily Boost of Radiation Therapy, Arm 2 Weekly Boost of Radiation Therapy)
Completed
- Breast Cancer
- Arm 1 Daily Boost of Radiation Therapy
- Arm 2 Weekly Boost of Radiation Therapy
-
New York, New YorkNYU Cancer Institute
Jan 15, 2021
Non-invasive Hemodynamic Measurement in Heart Failure Patients
Enrolling by invitation
- Congestive Heart Failure
- ezCVP measurement
-
Palo Alto, California
- +1 more
Jun 28, 2022
Metastatic Breast Cancer Trial (Pertuzumab (ZRC-3277), Pertuzumab (Perjeta®))
Not yet recruiting
- Metastatic Breast Cancer
- Pertuzumab (ZRC-3277)
- Pertuzumab (Perjeta®)
- (no location specified)
Jul 11, 2022
Lymphocytic Leukemia, Chronic, Lymphoma, Non Hodgkin Trial in Worldwide (BTCT4465A (Mosunetuzumab) IV, Atezolizumab, BTCT4465A
Recruiting
- Lymphocytic Leukemia, Chronic
- Lymphoma, Non Hodgkin
- BTCT4465A (Mosunetuzumab) IV
- +2 more
-
Duarte, California
- +55 more
Aug 4, 2022
Acute Lymphoid Leukemia Trial in Seoul (Blincyto)
Not yet recruiting
- Acute Lymphoid Leukemia
-
Seoul, Gangnam-gu, Korea, Republic of
- +4 more
Apr 12, 2023
Factors Affecting BAT Activation in PET/CT
Not yet recruiting
- Factors Affecting BAT Activation in PET/CT
- PET/CT
- (no location specified)
Oct 9, 2022
Herpes Zoster Trial (Peginterferon a1b, Peginterferon a1b with valacyclovir, Valacyclovir)
Not yet recruiting
- Herpes Zoster
- Peginterferon α1b
- +2 more
- (no location specified)
Aug 5, 2022
Longitudinal Pancreatic Cancer Study
Completed
- Pancreatic Cancer
- CA 19-9 Assay
-
Boca Raton, Florida
- +6 more
Aug 16, 2021
Rotavirus Gastroenteritis Trial in Surakarta, Yogyakarta (Rotavirus RV3 Vaccine (Bio Farma), Placebo)
Active, not recruiting
- Rotavirus Gastroenteritis
- Rotavirus RV3 Vaccine (Bio Farma)
- Placebo
-
Surakarta, Indonesia
- +20 more
Aug 26, 2022
Rectal Cancer Trial in Basking Ridge, Commack, New York (Rifaximin, Placebo)
Active, not recruiting
- Rectal Cancer
- Rifaximin
- Placebo
-
Basking Ridge, New Jersey
- +2 more
Sep 21, 2021
Breast Cancer Metastatic, Hormone Receptor Positive Malignant Tumor of Breast Trial in Spain (Combination, Rogaratinib +
Recruiting
- Breast Cancer Metastatic
- Hormone Receptor Positive Malignant Neoplasm of Breast
- Combination, Rogaratinib + palbociclib + fulvestrant
-
Hospitalet de Llobregat, Barcelona, Spain
- +7 more
Feb 8, 2022
Metastatic Breast Cancer Trial in Seoul (Fulvestrant plus AI plus ribociclib, AI plus ribociclib)
Not yet recruiting
- Metastatic Breast Cancer
- Fulvestrant plus AI plus ribociclib
- AI plus ribociclib
-
Seoul, Korea, Republic ofKorea university Guro hospital
Apr 16, 2023
Coronary Artery Bypass Surgery Trial in Patras (Coronary angiography +/- percutaneous coronary intervention, CT-Coronary
Recruiting
- Coronary Artery Bypass Surgery
- Coronary angiography +/- percutaneous coronary intervention
- CT-Coronary Angiography + Coronary angiography +/- percutaneous coronary intervention
-
Patras, Achaia, GreeceUniversity Hospital of Patras
Apr 12, 2022
Breast Cancer Trial in Sweden (Omission of axillary clearance)
Recruiting
- Breast Cancer
- Omission of axillary clearance
-
Gothenburg, Sweden
- +21 more
Apr 4, 2022
Post Operative Pain Trial in Oklahoma City (Gabapentin, Placebo)
Recruiting
- Post Operative Pain
- Gabapentin
- Placebo
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Jan 9, 2023
Brain Metastases From NSCLC (NSCLC) Trial in Worldwide (NovoTTF-200M device, Best Standard of Care)
Recruiting
- Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
- NovoTTF-200M device
- Best Standard of Care
-
Birmingham, Alabama
- +109 more
Jun 21, 2022
Leukemia Trial in New York (therapeutic autologous lymphocytes, cyclophosphamide)
Active, not recruiting
- Leukemia
- therapeutic autologous lymphocytes
- cyclophosphamide
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 18, 2021